Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 8
Submit an article Journal homepage
114
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Mantle cell lymphoma with dot-like nuclear staining for cyclin D1

Hoyuri FuseyaDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Masahiro YoshidaDepartment of Hematology, Osaka City General Hospital, Osaka, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5154-189X
ORCID Icon,
Rie OyamaDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Naoko TatsumiDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Minako TsutsumiDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Yosuke NakayaDepartment of Hematology, Osaka City General Hospital, Osaka, Japan; ORCID Iconhttp://orcid.org/0000-0003-3337-1599
ORCID Icon,
Mirei HoriuchiDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Takuro YoshimuraDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Yoshiki HayashiDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Takafumi NakaoDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
,
Ryoko SakagamiClinical Research Center, Osaka City General Hospital, Osaka, Japan;
,
Takane AoyamaClinical Research Center, Osaka City General Hospital, Osaka, Japan;
,
Nozomi NozuchiDepartment of Pathology, Osaka City General Hospital, Osaka, Japan
,
Hiroko FukushimaDepartment of Pathology, Osaka City General Hospital, Osaka, Japan
,
Takeshi InoueDepartment of Pathology, Osaka City General Hospital, Osaka, Japan
&
Takahisa YamaneDepartment of Hematology, Osaka City General Hospital, Osaka, Japan;
show all
Pages 2016-2019 | Received 17 Jan 2020, Accepted 18 Apr 2020, Published online: 12 May 2020

References

  • Yatabe Y, Suzuki R, Tobinai K, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood. 2000;95:2253–2261.
  • Swerdlow SC, Seto M, Muller-Hermelink HK. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: International Agency for Research on Cancerr (IARC); 2017. p. 285–290.
  • Bertoni F, Ponzoni M. The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol. 2007;39(10):1747–1753.
  • Delarue R, Haioun C, Ribrag V, et al. CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d’Etude des Lymphomes de l’Adulte. Blood. 2013;121(1):48–53.
  • Visco C, Chiappella A, Nassi L, et al. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi. Lancet Haematol. 2017;4(1):e15–e23.
  • Bernard M, Gressin R, Lefrere F, et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia. 2001;15(11):1785–1791.
  • Dreyling M, Campo E, Hermine O, et al. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv62–iv71.
  • Chen YH, Gao J, Fan G, et al. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod Pathol. 2010;23(1):105–112.
  • Zeng W, Fu K, Quintanilla-Fend L, et al. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol. 2012;36(2):214–219.
  • Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94(11):1555–1562.
  • Avet-Loiseau H, Garand R, Gaillard F, et al. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia. Genes Chromosom Cancer. 1998;23(2):175–182.
  • Iaccarino I, Afify L, Aukema SM, et al. t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform. Haematologica. 2018;103(9):e432–e435.
  • Yang WI, Zukerberg LR, Motokura T, et al. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol. 1994;145(1):86–96.
  • Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol. 2003;120(5):760–766.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.